IL18 and myeloid sarcoma: Over-activation of NLRP3 inflammasome activation is implicated in MS pathogenesis as evidenced by elevated levels of caspase-1 and IL-18 in MS patients serum and cerebrospinal fluid (CSF) (Losy and Niezgoda 2001; Keane et al. 2018).